2
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Prostatic Neoplasms
29
Breast Neoplasms
28
Brain Neoplasms
21
Neoplasms
16
Glioma
10
Pancreatic Neoplasms
9
Head and Neck Neoplasms
8
Lymphoma
7
Uterine Cervical Neoplasms
6
Urinary Bladder Neoplasms
6
Rectal Neoplasms
6
Glioblastoma
6
Colonic Neoplasms
6
Carcinoma, Hepatocellular
6
Lymphoma, Non-Hodgkin
5
Lung Neoplasms
5
Astrocytoma
5
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Liver Neoplasms
4
Disease
4
Central Nervous System Neoplasms
4
Stomach Neoplasms
3
Spinal Cord Neoplasms
3
Sarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Esophageal Neoplasms
3
Carcinoma in Situ
3
Retinoblastoma
2
Pathologic Complete Response
2
Interventions
3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol
6
pimonidazole
4
fluoroazomycin arabinoside
4
TH 302
4
Radiotherapy
4
Propofol
3
Injections
3
Positron Emission Tomography Computed Tomography
2
Drug Therapy
2
Blood Specimen Collection
2
Bacterial Load
2
pomalidomide
1
pembrolizumab
1
inositol trispyrophosphate
1
gadobutrol
1
fluoromisonidazole
1
fludarabine
1
alovudine
1
Tirapazamine
1
Thoracotomy
1
Thoracic Surgery, Video-Assisted
1
Temozolomide
1
Surgical Procedures, Operative
1
Sodium Chloride
1
Sevoflurane
1
Saline Solution
1
Pancreaticoduodenectomy
1
Paclitaxel
1
Oxygen
1
Nitroglycerin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hypoxia
×
Magnetic Resonance Imaging
×
Clear all
NCT05029258
2026-05-12
Bio-CHECC
University of Manchester
Active not recruiting
30 enrolled